BEIJING GENE+ TECHNOLOGY
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the implementation of precision medicine. The company claims to operate in around 100 hospitals and have served thousands of cancer patients in China.
BEIJING GENE+ TECHNOLOGY
Social Links:
Industry:
Health Care Life Science Medical
Founded:
2015-01-01
Address:
Changping, Beijing, China
Country:
China
Website Url:
http://www.geneplus.org.cn
Total Employee:
11+
Status:
Active
Total Funding:
181.29 M USD
Technology used in webpage:
Euro SPF Content Delivery Network LetsEncrypt JsDelivr Pound Sterling Common Name Invalid Japanese Yen Invalid Certificate Dates Nginx 1.14
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
CCB Capital
CCB Capital investment in Series C - Beijing Gene+ Technology
Alibaba Health Information Technology
Alibaba Health Information Technology investment in Series C - Beijing Gene+ Technology
CCB International
CCB International investment in Series C - Beijing Gene+ Technology
GGV Capital
GGV Capital investment in Series C - Beijing Gene+ Technology
Harvest Capital
Harvest Capital investment in Series C - Beijing Gene+ Technology
Fortune Capital
Fortune Capital investment in Series C - Beijing Gene+ Technology
Baidu Ventures
Baidu Ventures investment in Series C - Beijing Gene+ Technology
UEC Group
UEC Group investment in Series B - Beijing Gene+ Technology
Green Pine Capital Partners
Green Pine Capital Partners investment in Series B - Beijing Gene+ Technology
Co-Stone Venture Capital
Co-Stone Venture Capital investment in Series B - Beijing Gene+ Technology
Official Site Inspections
http://www.geneplus.org.cn Semrush global rank: 1.11 M Semrush visits lastest month: 24.88 K
- Host name: 223.71.218.81
- IP address: 223.71.218.81
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Beijing Gene+ Technology"
home [en.geneplus.cn]
Founded in 2015, GenePlus is an innovation company dedicated to medical research and clinical translation application. Based on next generation sequencing technology, GenePlus develops total solution covering oncology …See details»
吉因加 | 首页
近日，北京吉因加医学检验实验室获得由美国医疗保险和医疗补助服务中心（CMS）颁布的CLIA证书。此次获得认证，代表权威机构对吉因加临床检验报告结果准确性及可靠性的高度认可，意 …See details»
Gene+ - Crunchbase Company Profile & Funding
Gene+ is a biotechnology company offering genetic research, gene panel development, mutation detection, and tumor gene detection services.See details»
Beijing Gene+ Technology - Crunchbase Company …
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the …See details»
Gene+ | 领英 - 领英 (中国)
Gene+ | 在领英上有 741 位关注者。Omics for better health | Founded in 2015, Gene+ is a genetic testing and precision oncology company dedicated to the development and commercialization …See details»
吉因加 | 关于我们 - web.zh.geneplustest.geneplus.org.cn
吉因加创立于2015年，是诞生于精准医疗大背景下的创新型高科技企业。公司坚持国产自主战略， 以检测大平台、制造大平台和数据大平台为载体，提供面向医学、科技、健康三大业务方向的 …See details»
吉因加 | 检测大平台 - geneplus.cn
吉因加在北京、苏州、深圳、上海、长沙、成都六地建有医学检验实验室，获得国家卫健委批准的第三方独立医学检验室实验室资质。 实验室配备DNBSEQ-T7、Gene + Seq系列国产高通量 …See details»
吉因加 | 创新DNA - web.zh.geneplustest.geneplus.org.cn
吉因加基于液体活检、单细胞、多组学等多项前瞻性技术研发，推动“临床+科研”的转化医学应用研究，已打造专业、学术、值得信赖的业内品牌影响力。 公司主持和参与国家、省市级科技项 …See details»
Geneplus-Beijing · GitHub
Bioinformatic Center of Geneplus-Beijing. Geneplus-Beijing has 29 repositories available. Follow their code on GitHub.See details»
GenePlus - 健康客户服务平台
©2025Geneplus Technology All rights reserved. 吉因加科技版权所有。See details»
吉因加 | 首页 - GenePlus
吉因加创立于2015年4月，是诞生于精准医疗大背景下的创新型高科技企业。公司坚持国产自主战略，以NGS为底层技术，面向医学、科技、健康三大业务方向，依托全流程智能化平台，打 …See details»
GenePlus 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for GenePlus. Use the PitchBook Platform to explore the full profile.See details»
BDCG-6
2022基因大数据年会 吉因加品牌盛会，创新应用、价值共享，7月16-21日重磅上演！See details»
吉因加 | 新闻资讯 - geneplus.cn
近日，上海胸科医院陆舜教授团队领衔，北京肿瘤医院、广西医科大学附属第一医院、山西白求恩医院等14家分中心（见下文）与吉因加共同参与的一项前瞻性多中心TRACELib002项目研究 …See details»
吉因加 | 首页 - en.geneplus.cn
吉因加创立于2015年4月，是诞生于精准医疗大背景下的创新型高科技企业。公司坚持国产自主战略，以NGS为底层技术，面向医学、科技、健康三大业务方向，依托全流程智能化平台，打 …See details»
吉因加 | 制造大平台 - web.zh.geneplustest.geneplus.org.cn
吉因加在苏州和长沙建有医疗器械研发、生产与注册基地，设有医疗器械设备生产车间、十万级诊断试剂生产车间、万级诊断试剂生产车间、十万级检验室及辅助区以及原料制造平台，能够进 …See details»
百例基因咨询义诊报名 | 肠癌直播专场落幕，我们在基因门诊为您 …
以上资料清晰拍照后，发送到 [email protected] 邮箱；邮件标题：患者姓名-病例征集-拟就诊日期（不是预约日期）（如张三-病例征集-20200429）或添加工作人员微信号报名咨 …See details»
GenePlus - 吉因加临床检测管理系统
吉因加临床检测管理系统提供基因检测数据管理和分析服务，支持用户登录、查看和下载检测报告。See details»
在线义诊开通，吉因加联手医联搭建肿瘤防治一体化平台
目前，新冠肺炎疫情防控工作已经进入最关键的时期。 但是，还有一个特殊人群正在饱受疫情和疾病带来的双重困扰，他们就是肿瘤患者及其家属。一方面，他们随着病情发展对肿瘤治疗有紧 …See details»
吉因加 | 早期肿瘤术后五年关爱计划
吉因加联合京东健康、火山引擎、灯塔肿瘤医生、咚咚肿瘤科、患友之家等平台共同推广的“愈实惠·惠健康 五年关爱 惠民共创”项目，旨在为早期肿瘤术后患者提供以MRD检测 (基线+逐次) 为 …See details»